whether angiotensin receptor blockers increase cancer or cardiovascular risk
ARBs and cancer. A recent meta-analysis started a buzz that ARBs might lead to a small increased cancer risk...about 1 more case for every 143 patients using an ARB instead of placebo for 4 years.
One theory is that angiotensin might be involved in cell growth. ARBs increase free angiotensin by blocking its receptors.